These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9512079)

  • 1. Effects of the serotonin agonists 8-OH-DPAT, buspirone, and DOI on water maze performance.
    Kant GJ; Wylie RM; Chu K; Ghosh S
    Pharmacol Biochem Behav; 1998 Mar; 59(3):729-35. PubMed ID: 9512079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the serotonin receptor agonists 8-OH-DPAT and TFMPP on learning as assessed using a novel water maze.
    Kant GJ; Meininger GR; Maughan KR; Wright WL; Robinson TN; Neely TM
    Pharmacol Biochem Behav; 1996 Feb; 53(2):385-90. PubMed ID: 8808148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroendocrine responses to the serotonin2 agonist DOI are differentially modified by three 5-HT1A agonists.
    Li Q; Rittenhouse PA; Levy AD; Alvarez Sanz MC; Van de Kar LD
    Neuropharmacology; 1992 Oct; 31(10):983-9. PubMed ID: 1359439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the elevated plus-maze the anxiolytic-like effects of the 5-HT(1A) agonist, 8-OH-DPAT, but not the anxiogenic-like effects of the 5-HT(1A) partial agonist, buspirone, are blocked by the 5-HT1A antagonist, WAY 100635.
    Collinson N; Dawson GR
    Psychopharmacology (Berl); 1997 Jul; 132(1):35-43. PubMed ID: 9272757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-HT1A and muscarinic acetylcholine receptors jointly regulate passive avoidance behavior.
    Riekkinen P
    Eur J Pharmacol; 1994 Sep; 262(1-2):77-90. PubMed ID: 7813581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
    Kleven MS; Assié MB; Koek W
    J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic imipramine treatment sensitizes 5-HT1A and 5-HT 2 A receptors in the dorsal periaqueductal gray matter: evidence from the elevated T-maze test of anxiety.
    Zanoveli JM; Nogueira RL; Zangrossi H
    Behav Pharmacol; 2005 Nov; 16(7):543-52. PubMed ID: 16170231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-HT1A receptor agonist (8-OH-DPAT) and 5-HT2 receptor agonist (DOI) disrupt the non-cognitive performance of rats in a working memory task.
    Ruotsalainen S; MacDonald E; Koivisto E; Stefanski R; Haapalinna A; Riekkinen P; Sirviö J
    J Psychopharmacol; 1998; 12(2):177-85. PubMed ID: 9694031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of selective serotonin and dopamine agonists on plasma levels of glucose, insulin and glucagon in the rat.
    Uvnäs-Moberg K; Ahlenius S; Alster P; Hillegaart V
    Neuroendocrinology; 1996 Mar; 63(3):269-74. PubMed ID: 8677015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decision time and perseveration of adolescent rats in the T-maze are affected differentially by buspirone and independent of 5-HT-1A expression.
    Rhoads DE; Grimes N; Kaushal S; Mallari J; Orlando K
    Pharmacol Biochem Behav; 2012 Jul; 102(1):58-63. PubMed ID: 22494991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of buspirone and ipsapirone on schedule induced polydipsia: comparison with 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) and raclopride.
    Ryan CN; Evenden JL; Petterson M
    Psychopharmacology (Berl); 1993; 112(1):34-44. PubMed ID: 7871008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of 5-HT1A and 5-HT2/5-HT1C receptors induce oxytocin release in the male rat.
    Bagdy G; Kalogeras KT
    Brain Res; 1993 May; 611(2):330-2. PubMed ID: 8334526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of alpha 2-adrenoceptor antagonists on the inhibition of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-induced head shakes by 5-HT1A receptor agonists in the mouse.
    Dursun SM; Handley SL
    Br J Pharmacol; 1993 Aug; 109(4):1046-52. PubMed ID: 8104640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of long-term treatment with the 5-HT1A receptor agonist 8-OH-DPAT and the 5-HT2/1C receptor agonist DOI in the neonatal rat.
    Johansson-Wallsten CE; Berg M; Meyerson BJ
    Eur J Pharmacol; 1993 Oct; 243(2):149-54. PubMed ID: 8276064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of 5-HT
    Fletcher PJ; Zeeb FD; Browne CJ; Higgins GA; Soko AD
    Psychopharmacology (Berl); 2017 Mar; 234(5):889-902. PubMed ID: 28097374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modification of sexual behavior of Long-Evans male rats by drugs acting on the 5-HT1A receptor.
    Rehman J; Kaynan A; Christ G; Valcic M; Maayani S; Melman A
    Brain Res; 1999 Mar; 821(2):414-25. PubMed ID: 10064829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuronal circuits involved in the anxiolytic effects of the 5-HT1A receptor agonists 8-OH-DPAT ipsapirone and buspirone in the rat.
    Schreiber R; De Vry J
    Eur J Pharmacol; 1993 Nov; 249(3):341-51. PubMed ID: 7904566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypothalamic infusion of the 5-HT2/1C agonist, DOI, prevents the inhibitory actions of the 5-HT1A agonist, 8-OH-DPAT, on lordosis behavior.
    Uphouse L; Andrade M; Caldarola-Pastuszka M; Maswood S
    Pharmacol Biochem Behav; 1994 Mar; 47(3):467-70. PubMed ID: 8208763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Buspirone enhances immobility in the forced swim test in mice.
    Kitamura Y; Nagatani T
    Pharmacol Biochem Behav; 1996 Nov; 55(3):445-51. PubMed ID: 8951987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-induced defaecation in rats: role of central 5-HT1A receptors.
    Croci T; Landi M; Bianchetti A; Manara L
    Br J Pharmacol; 1995 May; 115(1):203-9. PubMed ID: 7647978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.